Jason Paul Steik - 17 Apr 2025 Form 3 Insider Report for Pennant Group, Inc. (PNTG)

Reporting relationship
Chief Clinical Officer
Issuer ticker
PNTG
Reported as of
17 Apr 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
31 Jul 2025, 11:49:30 UTC
Next SEC filing
12 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kirk Cheney, as attorney in fact

Key filing fact

Jason Paul Steik filed Form 3 for Pennant Group, Inc. (PNTG) on 31 Jul 2025.

Key facts

  • This page summarizes Jason Paul Steik's Form 3 filing for Pennant Group, Inc. (PNTG).
  • 0 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 31 Jul 2025, 11:49.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002078374 Primary reporting owner

Steik Jason Paul

Relationship
Chief Clinical Officer
Address
1675 E. RIVERSIDE DR, SUITE 150, EAGLE
Signature
/s/ Kirk Cheney, as attorney in fact
Signature date
31 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PNTG holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,500
Date
17 Apr 2025
Ownership
Direct
PNTG holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
647
Date
17 Apr 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$37.70
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$38.88
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$31.54
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,000
Exercise price
$24.04
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,000
Exercise price
$14.13
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,000
Exercise price
$15.02
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$12.52
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$18.79
Footnotes
F2
PNTG holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,000
Exercise price
$30.22
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The securities reported herein were acquired through open market purchases prior to the date the reporting person became an Officer of the Issuer.

Footnote F2

The awards vest in five equal annual installments beginning on the first anniversary of the date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .